Investor relations Header image

Investors
& Media

At Kezar Life Sciences, we are developing first-in-class, small molecule therapies designed to inhibit multiple disease-driving cellular pathways by targeting key intracellular proteins.

News

molecule background image large

molecule background image small

Corporate Presentation

Investor &
Media
Contact